Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
3000 participants
INTERVENTIONAL
2014-07-31
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-risk individuals
The elder and heavy smokers, which are high-risk individuals for early lung cancer. These subjects will be examined using "Observer nodule detection" and " Computer-aided nodule detection".
Observer nodule detection
Radiologists will detect the nodules.
Computer-aided nodule detection
Computed-aided detection (CAD) software will be used to detect the nodules.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observer nodule detection
Radiologists will detect the nodules.
Computer-aided nodule detection
Computed-aided detection (CAD) software will be used to detect the nodules.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 50 or older ,20 or more pack-year history of smoking, and one additional risk factor (occupational exposure, residential radon exposure, cancer history, family history of lung cancer, history of lung disease)
* Age 35 and one additional risk factor
* Ability to accept LDCT examination and sign informed consent form
Exclusion Criteria
* Individuals with acute pulmonary abnormalities or those in poor health conditions or those have metallic implants or devices in the chest or back will be excluded due to the potential impact on the results as well as difficulty of acquiring the images.
* Pregnant women
35 Years
74 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Shanghai Pulmonary Hospital, Shanghai, China
OTHER
Fudan University
OTHER
Ruijin Hospital
OTHER
Shanghai Public Health Clinical Center
OTHER_GOV
Shanghai Changzheng Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liu ShiYuan
Shanghai Changzheng Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shiyuan Liu, MD
Role: STUDY_DIRECTOR
Radiology Department of Shanghai Changzheng Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changzheng Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shiyuan Liu, Prof.MD.PhD.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13411950100
Identifier Type: -
Identifier Source: org_study_id